Is autologous cell therapy a realistic proposition for solid tumors?

Inhalers still don’t work as well as they should, but computational modeling is here to help.

AI is expanding into medicine. Are the world’s regulators ready?

Aging digital systems limit the potential of decentralized trials. It's time to rethink the technologies driving them.

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

In the 20th century, physics and chemistry reshaped the world. Here’s why biology will be the game-changer in the 21st century.

What are the challenges and best practices in quality control for difficult-to-inspect products?

Has pharma fully acknowledged the power of rapid-dissolve tablet technologies?

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value.

Salicylanilides have been a reliable treatment against tapeworms for much of pharma’s history. Now, they could be used to help fight COVID-19.